Answer

Access is limited. Options include:

  • Health Canada’s Special Access Program (SAP)
  • Clinical trials at research institutions
  • Section 56 exemptions for compassionate use in certain cases

TheraPsil and other non-profit organizations help eligible patients apply for legal access.